Skip to main content

Table 1 Characteristics at ICD implant of the 118 patients analyzed regarding KCCQ-12

From: Health status measured by Kansas City Cardiomyopathy Questionnaire-12 in primary prevention implantable cardioverter defibrillator patients with heart failure

 

n (%)

Patients

118

Mean age at implant (years)

65.0 ± 10.4

Mean age at KCCQ (years)

70.9 ± 9.8

Females

20 (16.9)

Ischemic etiology

69 (58.5)

Device type

 ICD-VR

16 (13.6)

 ICD-DR

45 (38.1)

 CRT-D

57 (48.3)

Hypertension

54 (45.8)

Diabetes mellitus

27 (22.9)

Renal failure*

16 (13.6)

Atrial fibrillation

35 (29.7)

Beta-blockers

106 (89.8)

ACE-i/ARB

111 (94.1)

MRA

75 (63.6)

  1. Data presented as frequencies (percentage in parenthesis)
  2. ACE-i angiotensin converting enzyme inhibitor, ARB angiotensin receptor blockers, CRT-D cardiac resynchronization therapy defibrillator, ICD-DR dual lead implantable cardioverter defibrillator, ICD-VR single lead implantable cardioverter defibrillator, KCCQ-12 12-item Kansas City Cardiomyopathy Questionnaire, MRA mineralcorticoid receptor antagonists
  3. *Defined as S-Creatinine ≥ 130 μmol/L